BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
CALL
Cognizant
CTSH
$26.2B
| $360K | ﹤0.01% |
58
| – | – |
|
2552
CALL
Invesco
IVZ
$13.9B
| $360K | ﹤0.01% |
200
| – | – |
|
2553
iShares MSCI Thailand ETF
THD
$354M
| $360K | ﹤0.01% |
4,105
+1,925
| +88% | +$169K |
|
|
BBT
2554
Beacon Financial Corp
BBT
$2.71B
| $359K | ﹤0.01% |
10,906
+2,542
| +30% | +$79.7K |
|
|
LNW
2555
DELISTED
Light & Wonder
LNW
| $358K | ﹤0.01% |
13,361
+2,784
| +26% | +$71.7K |
|
2556
TotalEnergies
TTE
$194B
| $356K | ﹤0.01% |
6,445
-9,773
| -60% | -$517K |
|
2557
Magnolia Oil & Gas
MGY
$6.25B
| $355K | ﹤0.01% |
28,238
+7,498
| +36% | +$84K |
|
2558
CTS Corp
CTS
$1.82B
| $355K | ﹤0.01% |
11,821
+6,634
| +128% | +$192K |
|
2559
First Busey Corp
BUSE
$2.58B
| $354K | ﹤0.01% |
12,890
+4,830
| +60% | +$128K |
|
2560
Frontdoor
FTDR
$5.89B
| $354K | ﹤0.01% |
7,468
-178,451
| -96% | -$8.36M |
|
|
SRCI
2561
DELISTED
SRC Energy Inc
SRCI
| $354K | ﹤0.01% |
85,864
+41,840
| +95% | +$159K |
|
2562
Papa John's
PZZA
$793M
| $353K | ﹤0.01% |
5,595
+1,359
| +32% | +$80.5K |
|
|
VRTU
2563
DELISTED
Virtusa Corporation
VRTU
| $352K | ﹤0.01% |
7,773
+2,906
| +60% | +$119K |
|
2564
United Fire Group
UFCS
$1.37B
| $351K | ﹤0.01% |
8,035
+4,240
| +112% | +$190K |
|
2565
Golar LNG
GLNG
$5.2B
| $351K | ﹤0.01% |
24,696
+5,128
| +26% | +$69.5K |
|
|
SAIL
2566
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $350K | ﹤0.01% |
14,848
-12,142
| -45% | -$266K |
|
|
MDP
2567
DELISTED
Meredith Corporation
MDP
| $349K | ﹤0.01% |
10,736
+1,590
| +17% | +$56.6K |
|
|
HEP
2568
DELISTED
Holly Energy Partners, L.P.
HEP
| $348K | ﹤0.01% |
15,725
-5,131
| -25% | -$117K |
|
|
RAVN
2569
DELISTED
Raven Industries Inc
RAVN
| $348K | ﹤0.01% |
10,106
+3,608
| +56% | +$123K |
|
|
WLL
2570
DELISTED
Whiting Petroleum Corporation
WLL
| $348K | ﹤0.01% |
632
+144
| +30% | +$69.6K |
|
2571
ICF International
ICFI
$1.6B
| $348K | ﹤0.01% |
3,796
+910
| +32% | +$78.3K |
|
2572
Evolent Health
EVH
$471M
| $348K | ﹤0.01% |
38,420
-6,795
| -15% | -$55.2K |
|
2573
Axsome Therapeutics
AXSM
$11.2B
| $348K | ﹤0.01% |
3,363
-1,002
| -23% | -$40.5K |
|
2574
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $348K | ﹤0.01% |
11,370
+3,418
| +43% | +$97.1K |
|
2575
ICU Medical
ICUI
$4.58B
| $346K | ﹤0.01% |
1,850
-11,485
| -86% | -$1.98M |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.